Hints and tips:
...It wasn’t an IPO or bond offering, but rather the $11.5bn takeover of Qiagen by Thermo Fisher....
Bank pursues business advising M&A buyers as well as sellers
...For Thermo Fisher the strategic merit is clear. The combination with Life’s life science business creates the world’s leading scientific test equipment business, with more than $16bn in revenue....
...Thermo Fisher was created in 2006 when Thermo Electron and Fisher Scientific International merged in a $12.8bn deal that created the biggest producer of scientific and laboratory equipment....
...The remaining bidders are, reportedly, a consortium of private equity firms and Thermo Fisher Scientific, the $30bn scientific equipment company....
...say, However, the private equity team believes the bid from Thermo Fisher, the scientific equipment company, will face antitrust issues, according to two people familiar with the matter....
...Thermo Fisher Scientific rose 3.8 per cent to $81.34 after it made a binding offer of more than $65 a share for genetic testing equipment maker Life Technologies ahead of a deadline on Tuesday....
...(Financial Times) Thermo Fisher nears $13bn Life Tech deal: “Thermo Fisher Scientific Inc is nearing a deal to buy genetic testing equipment maker Life Technologies Corp for close to $13 billion, according...
...(Financial Times) Thermo Fisher nears $13bn Life Tech deal: “Thermo Fisher Scientific is nearing a deal to buy genetic testing equipment maker Life Technologies Corp for close to $13bn, according to four...
...Fisher Scientific and buyout firms....
...The purchase of Phadia, which specialises in in-vitro allergy testing, is the group’s largest deal since the 2006 merger between Thermo Electron and Fisher Scientific....
...Thermo Fisher Scientific sold $2.1bn of debt to fund part of its $3.5bn acquisition of Phadia, a Swedish diagnostics maker....
...Cinven, the UK buy-out group, for example, sold Phadia, the allergy diagnosis company, to Thermo Fisher, the US medical equipment maker, last week in a €2.47bn ($3.48bn) deal that is set to support its current...
...Thermo Fisher Scientific, the US maker of scientific laboratory instruments, said that it would acquire Dionex in a $2.1bn deal that will help it expand its chromatography business....
...Carefusion added 2 per cent to $24.19 Thermo Fisher rose 1.9 per cent to $53.04 and Boston Scientific gained 3.5 per cent to $7.11....
...Thermo Fisher, which lost out to Germany’s Merck earlier this year in buying biotech equipment-maker Millipore, bought chromatography systems company Dionex for $2.1bn, while Dell snapped up Compellent Technologies...
...Thermo Fisher added 4.8 per cent to $55.56 after the scientific instruments maker said it would buy Dionex for $2.1bn....
...It was reported on Monday that rival Thermo Fisher Scientific had made an unsolicited bid for Millipore worth about $6bn....
...It trumps a $6bn approach by Thermo Fisher , a rival US company, and represents a 50 per cent premium to Millipore’s earlier share price. Thermo Fisher was 0.3 down to $48.65....
...Its shares gained more than 30 per cent last week in the wake of the reported Thermo Fisher offer and its strategic review....
...M&A news hit Thermo Electron after it said it was buying laboratory equipment maker Fisher Scientific to help expand its healthcare equipment business. Thermo Electron fell 2.3 per cent to $38.54....
...Among deals announced this year, Lazard is working for Gaz de France on its merger with Suez and Fisher Scientific on its merger with Thermo Electron....
International Edition